{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:17Z","timestamp":1785218417144,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Estrogen is an essential hormone that critically impacts bodily and brain functions, supporting learning, memory, and motor activities. A decrease in estrogen levels is associated with cognitive decline and motor dysfunction, such as muscle weakness. While conventional hormone replacement treatments (HRT) exist, those have limitations and potentially severe side effects. NAP (davunetide) is the smallest neuroprotective peptide site of activity-dependent neuroprotective protein (ADNP), a master regulator of cognition, essential for brain formation. It is known that NAP restores ADNP activity in cases of deficiency and it has already shown potential in preventing cognitive impairment, protecting against tauopathy, and improving motor function in various animal models and in clinical trials. Based on the dynamic regulation of ADNP by the estrous cycle and its involvement in steroidogenic pathways, we hypothesize that NAP may restore ADNP activity and thus serve as an alternative to conventional hormonal treatments. To test this hypothesis, 3-month-old female ICR mice underwent bilateral ovariectomy (OVX) or sham surgery and received daily intranasal administration of NAP, estrogen, or vehicle. Results showed a significant reduction in weight-normalized forelimb grip strength in the OVX model. Interestingly, grip strength was the only test that yielded significant OVX effects, and no significant differences were observed in the novel object recognition (NOR) test or computed tomography (CT) scans. Daily intranasal administration of either NAP or estrogen resulted in an apparent increase in the weight-normalized grip strength compared to the sham-treated OVX group. Furthermore, both the NAP- and the estrogen-treated OVX mouse groups did not statistically differ from the vehicle-treated sham control. These findings suggest that NAP may effectively prevent the loss of physical force production typically seen following ovarian hormone depletion, presenting a viable, non-hormonal candidate strategy for managing musculoskeletal symptoms. We hypothesize that the lack of significance OVX effects in other parameters was due to soy-derived phytoestrogens in the current Tel Aviv University\u2019s standard diet. Thus, the standard diet may have exerted a systemic estrogenic effect that masked the expected physiological phenotypes typically observed in OVX models. Future replication using phytoestrogen-deficient food is required to isolate the specific neuroprotective and musculoskeletal effects of NAP from dietary influence and clarify broader therapeutic benefits.<\/jats:p>","DOI":"10.3389\/fnins.2026.1891428","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:08Z","timestamp":1785217028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Activity-dependent neuroprotective protein (ADNP) derived peptide NAP prevents musculoskeletal abnormalities in ovariectomized mice"],"prefix":"10.3389","volume":"20","author":[{"given":"Liri Sophia","family":"Guz","sequence":"first","affiliation":[{"name":"The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Genetics and Computational Medicine, Gray Faculty of Medical and Health Sciences, Sagol School of Neuroscience and Adams Super Center for Brain Studies, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Galushkin","sequence":"additional","affiliation":[{"name":"The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Genetics and Computational Medicine, Gray Faculty of Medical and Health Sciences, Sagol School of Neuroscience and Adams Super Center for Brain Studies, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illana","family":"Gozes","sequence":"additional","affiliation":[{"name":"The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Genetics and Computational Medicine, Gray Faculty of Medical and Health Sciences, Sagol School of Neuroscience and Adams Super Center for Brain Studies, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2003.12.005","article-title":"Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.","volume":"361","author":"Alcalay","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","article-title":"Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.","volume":"72","author":"Bassan","year":"1999","journal-title":"J. Neurochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"B4","unstructured":"Sex hormones and health.\n          \n          24\n          28\n          \n            \n              Casey\n              C.\n            \n          \n          Nurs. N. Z.\n          23\n          2017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/brainsci15091003","article-title":"Beyond hot flashes: The role of estrogen receptors in menopausal mental health and cognitive decline.","volume":"15","author":"Cho","year":"2025","journal-title":"Brain Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0222040","DOI":"10.1371\/journal.pone.0222040","article-title":"Comparison between grip strength and grip strength divided by body weight in their relationship with metabolic syndrome and quality of life in the elderly.","volume":"14","author":"Chun","year":"2019","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms25031816","article-title":"Investigating the role of 17-Beta estradiol in the regulation of the unfolded protein response (UPR) in pancreatic beta cells.","volume":"25","author":"De Paoli","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3889\/oamjms.2019.086","article-title":"Phytoestrogens and their health effect.","volume":"7","author":"Desmawati","year":"2019","journal-title":"Open Access Macedonian J. Med. Sci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.70214","article-title":"Hormone replacement therapy for menopausal symptoms and the risk of cardiometabolic disease: Current evidence and future directions.","author":"Dong","year":"2026","journal-title":"BJOG Int. J. Obstetr. Gynaecol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nmeth.2252","article-title":"Measuring behavior of animal models: faults and remedies.","volume":"9","author":"Fonio","year":"2012","journal-title":"Nat. Methods"},{"key":"B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2004.09.077","article-title":"Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus.","volume":"373","author":"Furman","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"115573","DOI":"10.1016\/j.addr.2025.115573","article-title":"Intranasal NAP (Davunetide): Neuroprotection and circadian rhythmicity.","volume":"220","author":"Galushkin","year":"2025","journal-title":"Adv. Drug Delivery Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1697908","DOI":"10.3389\/fnins.2025.1697908","article-title":"Connectome-based predictive modeling of grip strength: A marker of physical frailty.","volume":"19","author":"Ghaffari","year":"2025","journal-title":"Front. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"608444","DOI":"10.3389\/fneur.2020.608444","article-title":"The ADNP syndrome and CP201 (NAP) potential and hope.","volume":"11","author":"Gozes","year":"2020","journal-title":"Front. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1111\/ejn.15920","article-title":"A novel davunetide (NAPVSIPQ Q to NAPVSIPQ E) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.","volume":"58","author":"Gozes","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41398-025-03675-y","article-title":"Systemic davunetide provides sex-specific neuroprotection during Coronary artery bypass grafting (CABG).","volume":"15","author":"Gozes","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41398-024-03118-0","article-title":"Davunetide sex-dependently boosts memory in prodromal Alzheimer\u2019s disease.","volume":"14","author":"Gozes","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1385\/JMN:20:3:315","article-title":"From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP.","volume":"20","author":"Gozes","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41398-023-02618-9","article-title":"Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women.","volume":"13","author":"Gozes","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41398-020-00904-4","article-title":"Tauopathy in the young autistic brain: Novel biomarker and therapeutic target.","volume":"10","author":"Grigg","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1172\/jci98199","article-title":"Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.","volume":"128","author":"Hacohen-Kleiman","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/bs.pmbts.2020.07.008","article-title":"Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.","volume":"177","author":"Ivashko-Pachima","year":"2021","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e3002082","DOI":"10.1371\/journal.pbio.3002082","article-title":"A multi-lab experimental assessment reveals that replicability can be improved by using empirical estimates of genotype-by-lab interaction.","volume":"21","author":"Jaljuli","year":"2023","journal-title":"PLoS Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/npp.2013.23","article-title":"Effects of davunetide on n-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.","volume":"38","author":"Jarskog","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.schres.2011.11.001","article-title":"Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.","volume":"136","author":"Javitt","year":"2012","journal-title":"Schizophr. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neubiorev.2018.01.003","article-title":"Reproducibility and replicability of rodent phenotyping in preclinical studies.","volume":"87","author":"Kafkafi","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nmeth.4259","article-title":"Addressing reproducibility in single-laboratory phenotyping experiments.","volume":"14","author":"Kafkafi","year":"2017","journal-title":"Nat. Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11357-019-00079-x","article-title":"ADNP differentially interact with genes\/proteins in correlation with aging: A novel marker for muscle aging.","volume":"41","author":"Kapitansky","year":"2019","journal-title":"GeroScience"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3390\/cells9102320","article-title":"Single cell ADNP predictive of human muscle disorders: Mouse knockdown results in muscle wasting.","volume":"9","author":"Kapitansky","year":"","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.3390\/ijms21186715","article-title":"Age and sex-dependent ADNP regulation of muscle gene expression is correlated with motor behavior: Possible feedback mechanism with PACAP.","volume":"21","author":"Kapitansky","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopsych.2021.09.018","article-title":"Novel ADNP syndrome mice reveal dramatic Sex-Specific peripheral gene expression with brain synaptic and TAU pathologies.","volume":"92","author":"Karmon","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1745210","DOI":"10.3389\/frph.2026.1745210","article-title":"The impact of hormone replacement therapy on cardiovascular health in postmenopausal women: A narrative review.","volume":"8","author":"Khalifey","year":"2026","journal-title":"Front. Reproductive Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/joe-15-0476","article-title":"Estrogens maintain skeletal muscle and satellite cell functions.","volume":"229","author":"Kitajima","year":"2016","journal-title":"J. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/01.str.0000014207.05597.d7","article-title":"NAP, a Femtomolar-Acting peptide, protects the brain against ischemic injury by reducing apoptotic death.","volume":"33","author":"Leker","year":"2002","journal-title":"Stroke"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102910","DOI":"10.1016\/j.xpro.2024.102910","article-title":"Protocol for ovariectomy and estradiol replacement in mice.","volume":"5","author":"Luengo-Mateos","year":"2024","journal-title":"STAR Protoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00065","DOI":"10.1002\/prp2.65","article-title":"Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing \u03b1$-$synuclein.","volume":"2","author":"Magen","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/ilar\/ilab016","article-title":"Mouse anesthesia: The art and science.","volume":"62","author":"Navarro","year":"2021","journal-title":"ILAR J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1055\/s-0028-1088304","article-title":"Selective estrogen receptor modulators and phytoestrogens.","volume":"74","author":"Oseni","year":"2008","journal-title":"Planta Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/mp.2014.97","article-title":"The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.","volume":"19","author":"Oz","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0165-3806(03)00162-7","article-title":"Activity-dependent neuroprotective protein: A novel gene essential for brain formation.","volume":"144","author":"Pinhasov","year":"2003","journal-title":"Dev. Brain Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.yfrne.2013.08.001","article-title":"Estrogen: A master regulator of bioenergetic systems in the brain and body.","volume":"35","author":"Rettberg","year":"2013","journal-title":"Front. Neuroendocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s13311-019-00766-9","article-title":"The role of estrogen in brain and cognitive aging.","volume":"16","author":"Russell","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1038\/s41380-024-02879-w","article-title":"ADNP is essential for sex-dependent hippocampal neurogenesis, through male unfolded protein response and female mitochondrial gene regulation.","volume":"30","author":"Shapira","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-4939-8994-2_29","article-title":"Description of ovariectomy protocol in mice.","volume":"1916","author":"Souza","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.21037\/atm.2020.02.57","article-title":"Effects of estrogen deprivation on memory and expression of related proteins in ovariectomized mice.","volume":"8","author":"Tao","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00002512-199914050-00003","article-title":"The adverse effects of hormone replacement therapy.","volume":"14","author":"Tavani","year":"1999","journal-title":"Drugs Aging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/jpet.107.129551","article-title":"Activity-Dependent Neuroprotective protein snippet NAP reduces TAU hyperphosphorylation and enhances learning in a novel transgenic mouse model.","volume":"323","author":"Vulih-Shultzman","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1011725","DOI":"10.3389\/fcell.2022.1011725","article-title":"Mechanisms of estrogen deficiency-induced osteoporosis based on transcriptome and DNA methylation.","volume":"10","author":"Xu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.steroids.2016.03.014","article-title":"Interplay between steroid hormone activation of the unfolded protein response and nuclear receptor action.","volume":"114","author":"Zheng","year":"2016","journal-title":"Steroids"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1891428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:10Z","timestamp":1785217030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1891428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":49,"alternative-id":["10.3389\/fnins.2026.1891428"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1891428","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1891428"}}